Table 1 Characteristics of insured patients initiating PEG-IFN-alfa and ribavirin treatment for chronic HCV infection
Characteristic | No. (%) of insured patients (n = 1269) |
|---|---|
Age, mean (SD), y | 50.2 (7.7) |
Age group (y) | |
18-29 | 31 (2.4) |
30-39 | 61 (4.8) |
40-49 | 405 (31.9) |
50-59 | 675 (53.2) |
60-69 | 91 (7.2) |
70+ | 6 (0.5) |
Female | 459 (36.2) |
Region | |
East | 123 (9.7) |
Midwest | 242 (19.1) |
South | 705 (55.6) |
West | 199 (15.7) |
Type of health benefits | |
Commercial | 1,244 (98.0) |
Medicaid-HMO | 25 (2.0) |
HIV/AIDS | 44 (3.5) |